subject area of
- A randomized study of alpha‐interferon plus ribavirin for 6 months or 12 months for the treatment of chronic hepatitis C in patients with bleeding disorders Journal Articles
- Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19 Journal Articles
- Adverse Events Associated with High‐Dose Ribavirin: Evidence from the Toronto Outbreak of Severe Acute Respiratory Syndrome Journal Articles
- Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus Journal Articles
- Chinese hamster ovary cell mutants specifically affected in the phosphorylation of C-purine nucleosides Journal Articles
- Ciliary Function, Cell Viability, and in Vitro Effect of Ribavirin on Nasal Epithelial Cells in Acute Rhinorrhea Journal Articles
- Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alfa‐2a plus ribavirin Journal Articles
- Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis Journal Articles
- Efficacy and Safety of Pegylated Interferon Alfa-2a or Alfa-2b Plus Ribavirin for the Treatment of Chronic Hepatitis C in Children and Adolescents: A Systematic Review and Meta-analysis Journal Articles
- Efficacy and safety of a two‐drug direct‐acting antiviral agent regimen ruzasvir 180 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4, 5 or 6 Journal Articles
- Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis Journal Articles
- Getting more out of meta-analyses: a new approach to meta-analysis in light of unexplained heterogeneity Journal Articles
- Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts Journal Articles
- Glucocorticoid Receptors, Brain-Derived Neurotrophic Factor, Serotonin and Dopamine Neurotransmission are Associated with Interferon-Induced Depression Journal Articles
- High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis C. Journal Articles
- Impact of Asian Race on Response to Combination Therapy With Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Journal Articles
- Inhibition of Warfarin Activity by Ribavirin Journal Articles
- Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label Study Journal Articles
- Letter to the Editor Journal Articles
- Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin Journal Articles
- Murine Trophoblast Failure and Spontaneous Abortion Journal Articles
- Network meta-analysis of direct-acting antivirals in combination with peginterferon–ribavirin for previously untreated patients with hepatitis C genotype 1 infection Journal Articles
- Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada) Journal Articles
- Paranoid psychosis and cognitive impairment associated with hepatitis C antiviral therapy Journal Articles
- Peginterferon Plus Ribavirin for Chronic Hepatitis C in Patients With Human Immunodeficiency Virus Journal Articles
- Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C Journal Articles
- Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C Journal Articles
- Real-world effectiveness of peginterferon α-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and RediPEN studies Journal Articles
- Responder Interferon λ Genotypes Are Associated With Higher Risk of Liver Fibrosis in HIV–Hepatitis C Virus Coinfection Conferences
- Retreatment with Pegylated Interferon Alpha-2a and Ribavirin in Patients with Chronic Hepatitis C Who Have Relapsed or Not Responded to a First Course of Pegylated Interferon-Based Therapy Journal Articles
- Suicide risk in hepatitis C and during interferon-alpha therapy: a review and clinical update Journal Articles
- The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation Journal Articles
- Treatment responses in Asians and Caucasians with chronic hepatitis C infection Journal Articles